In my first post on this blog, I set myself 3 PhD-related goals for 2017. One of those goals was to read more widely, and more frequently, and I decided that doing the #365papers challenge would be a good way to do that.

For the first time in a few months, I’m finishing July ahead of schedule! I’m currently writing this before I go on holiday (July 28th) and it’s been scheduled and published whilst I’m enjoying myself with friends in Wroclaw or Krakow, depending on when you’re reading this.

This month I’ve really focussed on getting abstracts screened for my literature review. I still have a big pile waiting for me when I get back to the office, but it feels good to have made at least a little dent in the workload, and the task definitely made reading much easier to fit in too.

July’s reading:

1. Marketing and clinical trials: a case study
2. Practical issues regarding implementing a randomized clinical trial in a homeless population: strategies and lessons learned
3. Avoidable waste related to inadequate methods and incomplete reporting of interventions: a systematic review of randomised trials performed in Sub-Saharan Africa
4. External validity of randomised controlled trials: “To whom do the results of this trial apply?”
5. Implementing research findings in developing countries
6. Spending on public health cut as councils look to save money
7. New law will force hospitals to charge foreign patients for non-urgent care
8. Participation in a clinical trial: The patients’ point of view
9. Clinical trial participation: Viewpoints from racial/ethnic groups
10. Barriers to clinical trial participation as perceived by oncologists and patients
11. Determinants of patient participation in clinical studies requiring informed consent: why patients enter a clinical trial
12. Patient income level and cancer clinical trial participation
13. Why African Americans may not be participating in clinical trials
14. Why patients don’t take part in cancer clinical trials: an overview of the literature
15. Resource implications of preparing individual participant data from a clinical trial to share with external researchers
16. Short-term impact of celebrating the international clinical trial day: experience from Ethiopia
17. How to design efficient cluster randomised trials
18. Six pairs of things to celebrate on International Clinical Trials Day
19. Development in the number of clinical trial applications in Western Europe from 2007 to 2015: retrospective study of data from national competent authorities
20. When scientists turn to the public: alternative routes in science communication
21. Blockchain technology for improving clinical research quality
22. Barriers to clinical trial recruitment and possible solutions: a stakeholder survey
23. Unsuccessful trial accrual and human subjects’ protections: an empirical analysis of recently closed trials
24. Routine data from hospital information systems can support patient recruitment for clinical studies
25. Impact of participant and physician intervention preferences on randomised trials – a systematic review
26. Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies
27. Informed consent documents do not encourage good-quality decision making
28. The effects of an open design on trial participant recruitment, compliance and retention – a randomized controlled trial comparison with a blinded, placebo-controlled design
29. Provider roles in the recruitment of underrepresented populations to cancer clinical trials
30. Recruiting subjects for acute stroke trials: a meta-analysis
31. Minimisation: a new method of assigning patients to treatment and control groups